Semnur Pharmaceuticals, Inc. (SMNR)

0.45 0.00 (0.00%) USD  |  OTCM  |  Sep 21, 16:00
More

Semnur Pharmaceuticals CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for SMNR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical CAPEX To Revenue (TTM) Data

View and export this data back to . Start Trial.
Date Value

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Scilex Holding Co. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. --
Johnson & Johnson Upgrade